NEW YORK (GenomeWeb) – Columbia University Medical Center and New York-Presbyterian announced a $58.4 million grant from the National Institutes of Health and its National Center for Advancing Translational Sciences (NCATS).

With the five-year grant, the Irving Institute for Clinical and Translational Research will invest further in personalized medicine. It will provide resources for training and research in personalized medicine and develop translational therapeutics.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.